Sinofn Health
Sinofn Health
The Global Nutrition Industrial Context: As we navigate the post-pandemic era, the nutraceutical landscape is undergoing a paradigm shift. We are moving from generic supplementation to "Precision Nutrition." As a leading ODM supplier, SINOFN integrates deep clinical research with scalable manufacturing to meet the demand for bio-available, science-backed solutions.
Technology Roadmap: Our focus is on Delivery System Innovation. From nano-emulsion technology to slow-release encapsulation, we ensure that bioactive compounds like Cyclic Adenosine Monophosphate (cAMP) and plant-based prebiotics maintain their efficacy through the digestive tract.
Localization Strategy: We understand that global markets have distinct regulatory requirements. Whether it's FDA compliance, EFSA standards, or local nutraceutical legislation, our factory operates under ISO22000 and FSSC 22000 frameworks, allowing our global partners to launch products seamlessly in diverse territories.
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group. Founded in 2012 and deeply backed by the Chinese Academy of Sciences, we bridge the gap between academic research and commercial industrialization. Established in 2025, our Shanghai hub serves global partners with premium contract manufacturing services.
Mrs. GuoHong Liu, driven by her clinical experience, founded SINOFN to solve real-world nutrition access issues, specifically for PKU patients. Her philosophy: "We measure success in lives improved."
Medical Innovation Director, PhD from Peking University Medical School. 15+ years in metabolic disorder formulations.
R&D Lead, CAS Postdoc. Expert in bioactive compound delivery systems.
Formulation Director. Senior Scientist from the Netherlands, specialized in EU regulatory standards.
Located in China, our facilities are hubs of high-tech production serving international markets with full export compliance.
Yes, we offer pilot-scale prototyping for tablets, capsules, and liquid forms to ensure market viability before mass production.
We serve both startups and large enterprises with flexible, tiered production scopes.
